ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Dogwood Therapeutics Inc

Dogwood Therapeutics Inc (DWTX)

1.87
-0.06
(-3.11%)
Closed January 17 4:00PM
1.96
0.09
(4.81%)
After Hours: 7:59PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
1.87
Bid
1.86
Ask
1.95
Volume
17,395
1.87 Day's Range 1.99
1.62 52 Week Range 5.29
Previous Close
1.93
Open
1.99
Last Trade
1
@
1.9499
Last Trade Time
Average Volume (3m)
46,882
Financial Volume
$ 33,344
VWAP
1.9169

DWTX Latest News

Dogwood Therapeutics, Inc. Announces Low Dose IMC-2 Treatment Reduces Long-COVID Related Fatigue and Sleep Disturbance in an Investigator-Initiated Study

- IMC-2 treatment, dosed as valacyclovir 750 mg + celecoxib 200 mg twice daily, demonstrated clinically meaningful reduction in Long-COVID related fatigue and sleep disturbance as compared to...

Dogwood Therapeutics Announces Third Quarter 2024 Financial Results

- Dogwood Therapeutics, Inc. (Nasdaq: “DWTX”) formed in October by combination of Virios Therapeutics, Inc. and Pharmagesic (Holdings) Inc., 100% parent company of Wex Pharmaceuticals, Inc. (the...

Dogwood Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Thursday, November 7, 2024

ATLANTA, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), formerly Virios Therapeutics, Inc., a clinical‐stage biopharmaceutical company, announced...

Dogwood Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement

ATLANTA, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), formerly Virios Therapeutics, Inc., a clinical‐stage biopharmaceutical company, announced...

Virios Therapeutics, Inc. and Wex Pharmaceuticals, Inc. Announce Business Combination to Form Dogwood Therapeutics, Inc. (Nasdaq: “DWTX”)

Strategic financing by an affiliate of CK Life Sciences Int’l., (Holdings) Inc., results in working capital of approximately $23 million to fund operations and advance Phase 2b Halneuron®...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.56-23.04526748972.432.441.87236662.11893433CS
4-0.44-19.04761904762.312.99991.87292142.51867708CS
12-2.63-58.44444444444.55.151.62468822.93173213CS
26-1.68-47.3239436623.555.291.62764013.46194376CS
52-1.68-47.3239436623.555.291.62764013.46194376CS
156-1.68-47.3239436623.555.291.62764013.46194376CS
260-1.68-47.3239436623.555.291.62764013.46194376CS

DWTX - Frequently Asked Questions (FAQ)

What is the current Dogwood Therapeutics share price?
The current share price of Dogwood Therapeutics is $ 1.87
What is the 1 year trading range for Dogwood Therapeutics share price?
Dogwood Therapeutics has traded in the range of $ 1.62 to $ 5.29 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BTCTBTC Digital Ltd
$ 8.2697
(73.73%)
61.45M
BDMDBaird Medical Investment Holdings Ltd
$ 8.80
(62.36%)
18.63M
CRKNCrown Electrokinetics Corporation
$ 0.1235
(54.96%)
764.86M
NUKKNukkleus Inc
$ 29.97
(45.98%)
19.09M
GSITGSI Technology
$ 3.97
(44.36%)
87.7M
DOGZDogness International Corporation
$ 18.23
(-58.77%)
740.45k
ORKTOrangeKloud Technology Inc
$ 3.02
(-24.88%)
21.08M
PMAXPowell Max Ltd
$ 0.6364
(-23.31%)
4.17M
LGCBLinkage Global Inc
$ 0.2876
(-22.27%)
890.66k
YYAIConnexa Sports Technologies Inc
$ 0.8299
(-20.20%)
602.48k
CRKNCrown Electrokinetics Corporation
$ 0.1235
(54.96%)
764.86M
GCTKGlucoTrack Inc
$ 0.0852
(15.45%)
465.22M
RIMEAlgorhythm Holdings Inc
$ 0.0406
(-4.02%)
387.23M
TGLTreasure Global Inc
$ 0.2459
(14.75%)
267.1M
NVDANVIDIA Corporation
$ 137.71
(3.10%)
201.4M

Your Recent History

Delayed Upgrade Clock